Early detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections
Scientists have discovered a molecule that could aid the development of new treatments for MND
Integrating the Compresstome Vibrating Microtome into the Agilent Seahorse XF Flex tissue workflow
Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities, especially using QIAcuity digital PCR
SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotency
Supported by 50 years of spectroscopy expertise, this subdivision aims to "deliver accuracy, consistency, and insight"
This collaboration aims to expand metabolite and lipid analysis through the power of mass spectrometry
New analytical instruments and innovative software to drive breakthroughs in biopharmaceutical discovery, translational omics and safer water quality
Three interrelated Body of Knowledge papers outline roles and required skills for bioinformaticians with respect to molecular diagnostics, clinical bioinformatics, clinical laboratory regulation and data security
Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions
Over 200 exhibitors, AI-powered breakthroughs, and strategic forums set to transform regional healthcare
How cross-disciplinary collaboration and earlier recognition can transform outcomes for patients with Crohn’s disease and ulcerative colitis
The partnership aims to support cell therapy researchers with a standardized and reliable MSC reference system
The ORCA-Halo combines cutting-edge reliable technology with excellent image quality performance
A key focus of the partnership will be the development of adeno-associated virus gene therapy programs using intellectual property from KU Leuven
Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies
The new site is still within the Midlothian Science Zone and is now fully operational, marking a significant milestone in the company’s continued growth
Licensing with a global enzyme provider for two Optimer reagents in research and diagnostics
New solutions from Siemens Healthineers address labs’ environmental and efficiency goals
BUCHI sets a new standard in material analysis, offering tailored solutions for quality assurance at every stage of the supply chain
The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress
